AMPD1 and adenosine monophosphate deaminase deficiency: Although 1–2% of the Caucasian population carries one of the mutations that cause myoadenylate deaminase deficiency, few carriers show symptoms [183] and the clinical relevance of AMPD1 deficiency has been questioned [189].